Skip to content
  • Saturday, 12 September 2026
  • 5:53 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy
Pharmaceutical R&D

Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy

Teuku Ryan Sep 12, 2026 0

In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…

Read More
Pharmaceutical R&D

Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline

Teuku Ryan Sep 10, 2026 0

Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…

Read More
Stem Cell & Regenerative Medicine

Scientists Replicate Human Bone Marrow Architecture Using Only Human Cells to Advance Blood Cancer Research and Reduce Animal Testing

Dwi Wanna Jul 21, 2026 0

The human bone marrow is often described as the body’s primary "blood factory," a highly sophisticated and specialized tissue responsible…

Read More
Stem Cell & Regenerative Medicine

Cornell University Breakthrough Marks Significant Advance Toward Long-Acting Nonhormonal Male Contraceptive

Dwi Wanna Jul 20, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have identified a biological pathway that could lead to…

Read More
Advanced Materials Science

NASA Upgrades Cold Atom Lab Aboard International Space Station to Advance Quantum Frontier

Nila Kartika Wati Jul 17, 2026 0

The International Space Station has reached a new milestone in the field of quantum physics as NASA’s Cold Atom Lab…

Read More
Pharmaceutical R&D

Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics

Teuku Ryan Jun 30, 2026 0

In a significant development poised to reshape the landscape of immunology therapeutics, New Jersey-based Talawar Therapeutics has officially merged with…

Read More
Stem Cell & Regenerative Medicine

Scientists Replicate Human Bone Marrow Architecture Using Stem Cell Technology to Advance Blood Cancer Research and Reduce Animal Testing

Dwi Wanna Jun 29, 2026 0

In a landmark achievement for regenerative medicine and hematology, researchers from the University of Basel and University Hospital Basel have…

Read More
Stem Cell & Regenerative Medicine

Indiana University Researchers Develop Breakthrough Multiplex Imaging Technique for Bone Marrow Analysis to Advance Disease Treatment

Dwi Wanna Jun 23, 2026 0

In a landmark achievement for the field of hematology and regenerative medicine, scientists at the Indiana University School of Medicine…

Read More
Advanced Materials Science

NASA Upgrades Cold Atom Lab to Advance Quantum Research on International Space Station

Nila Kartika Wati Jun 23, 2026 0

The National Aeronautics and Space Administration (NASA) has successfully restored and enhanced its Cold Atom Lab (CAL) aboard the International…

Read More
Pharmaceutical R&D

Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP

Teuku Ryan Jun 17, 2026 0

Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…

Read More

Posts pagination

1 2 … 4
Researchers Recreate Human Bone Marrow Niche Using Pluripotent Stem Cells to Advance Cancer Research and Reduce Animal TestingRetatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over NovoA Breakthrough Food Supplement Offers Hope for Reversing Alarming Honeybee DeclineTWiV 1284: Clinical update with Dr. Daniel Griffin
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ